Sarepta Therapeutics to Present Company Overview at Upcoming Conferences

Sarepta Therapeutics to Present Company Overview at Upcoming Conferences 
Webcast Accessible via Sarepta Therapeutics Website 
CAMBRIDGE, MA -- (Marketwired) -- 05/10/13 --  Sarepta Therapeutics
(NASDAQ: SRPT), a developer of innovative RNA-based therapeutics,
announced today that it is scheduled to present at the following
investor conferences in May. Chris Garabedian, Sarepta's president
and chief executive officer, will be the presenter. 

--  UBS Global Healthcare Conference in New York, NY on Tuesday, May 21,
    2013 at 8:30 a.m. Eastern Time.
--  Deutsche Bank's 38th Annual dbAccess Healthcare Conference in Boston,
    MA on Thursday, May 30, 2012 at 2:50pm Eastern Time.

The presentations will be webcast live on the investor relations
section of Sarepta Therapeutics' website at and will be archived under the events and
presentations section following the presentation for 90 days. Please
connect to Sarepta's website several minutes prior to the start of
the broadcast to ensure adequate time for any software download that
may be necessary. 
About Sarepta Therapeutics 
Sarepta Therapeutics is focused on developing first-in-class
RNA-based therapeutics to improve and save the lives of people
affected by serious and life-threatening rare and infectious
diseases. The Company's diverse pipeline includes its lead program
eteplirsen, for Duchenne muscular dystrophy, as well as potential
treatments for some of the world's most lethal infectious diseases.
Sarepta aims to build a leading, independent biotech company
dedicated to translating its RNA-based science into transformational
therapeutics for patients who face significant unmet medical needs.
For more information, please visit us at 
Sarepta Investor Contact: 
Erin Cox 
Sarepta Media Contact:
Jim Baker
Press spacebar to pause and continue. Press esc to stop.